Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals is a biotech company that develops drugs for brain and nerve disorders like epilepsy, depression, and chronic pain. The company's main product candidate, Azetukalner, is being tested in advanced human trials as a potential treatment for epilepsy and mood disorders. Xenon also has experimental drugs in early testing for pain relief, and partners with another company to develop an epilepsy treatment. The company was founded in Canada in 1996.